artesunic acid has been researched along with Central Nervous System Origin Vertigo in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, I; Edler, L; Hoth, S; König, M; Sertel, S; von Hagens, C; Walter-Sack, I | 1 |
| Ducret, JP; Essono, E; Lohoue, J; Ravinet, L; Same-Ekobo, A | 1 |
2 trial(s) available for artesunic acid and Central Nervous System Origin Vertigo
| Article | Year |
|---|---|
Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Audiometry; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Treatment Outcome; Vertigo | 2016 |
[Rapid resolution of Plasmodium ovale malarial attacks using artesunate (Arsumax)].
Topics: Acute Disease; Adolescent; Adult; Anemia; Animals; Antimalarials; Artemisinins; Artesunate; Cameroon; Fever; Humans; Malaria; Middle Aged; Parasitemia; Plasmodium; Reticulocytes; Sesquiterpenes; Time Factors; Vertigo | 1999 |